The Sleeping Giant

7 Key Takeaways

• 1

  Antibiotic development is hindered by a lack of profit.

• 2

  Innovative natural sources may provide new antibiotics.

• 3

  Government initiatives are crucial for funding.

• 4

  UK introduces a subscription payment model.

• 5

  The model compensates for unused antibiotics.

• 6

  Pharma must be proactive in funding R&D.

• 7

  There's a call for reassessment in antibiotic strategy.